FDA released a draft guidance on the use of AI to support regulatory decision-making for drugs

Last week the FDA released a draft guidance on the use of AI to support regulatory decision-making for drugs . Overall the guidance covers the basics for model development, training and testing and the special considerations based on the level of risk associated with the model. Reassuringly the guidance doesn’t deviate from many best practices that the industry has developed over the last decade.…